Help-Medical.Net

Cylene Pharmaceuticals, Inc. inclination despatch new developments with its first-in-class, word-of-mouth CK2 inhibitor CX-4945, at the 6th Supranational Bull session on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the public limited company announced today. CX-4945 is potentially a dynamical anticancer medicinal, as both a stand-alone dull and after usefulness in claque therapies. The engagement determination be attended Read the rest of this entry »

EDAP TMS SA (Nasdaq:EDAP), the international director in corrective ultrasound, today reported favorable clinical outcomes benefit of patients treated with Ablatherm-HIFU. A out-and-out of 803 patients with localized prostate cancer, treated with Ablatherm-HIFU from 1993 until 2007, were reported in a library carried unlit near Dr. Sébastien Crouzet, Urologist at Edouard Herriot Asylum, Lyon, France. The interpretation has been published electronically Read the rest of this entry »

ImmunoCellular Therapeutics (OTCBB: IMUC), a biotechnology callers focused on the circumstance of unfamiliar immune-based cancer therapies, today announced long-term figures from a Point of view I clinical essay of ICT-107, the Company’s possibility cancervaccine seeker in requital for the treatment of glioblastoma multiforme (GBM), the most customary and assertive convention of braincancer. The evidence usher six tired of 16 (37.6%) patients Read the rest of this entry »

Conspectus: GSK and Genmab hint at the ritual of a Inject III studio of ofatumumab in rituximab refractory patients with slothful B-cell non-Hodgkin’s Lymphoma.

GlaxoSmithKline (GSK) and Genmab A/S (Copenhagen:GEN) announced today the start of a Insinuate III analyse in patients with listless B-cell non-Hodgkin’s lymphoma (B-NHL) who did not rejoin to or progressed during, or within 6 months of a rituximab containing regimen. Down the Read the rest of this entry »

Tetraphase Pharmaceuticals, Inc., today announced that 12 notice presentations and an said distillate conferral on preclinical and clinical facts towards its margin remedy runner, TP-434, wishes be presented at the 2010 Interscience Colloquy on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA, being held September 12 -15 at the Boston Congress and Display Center. Tetraphase Pharmaceuticals is a clinical tier biopharmaceutical business Read the rest of this entry »

ImmunoCellular Therapeutics (OTCBB: IMUC) issued the following Erudition to Shareholders today:

Cherished Shareholders,

As the summer comes to a tight, I wanted to update you on the Company’s accomplishments this year, which get under way the broadway through despite an rousing get the show on the road. The commencement eight months of the year possess been terribly famed, with the Business attaining numberless of its goals, Read the rest of this entry »

Iroko Cardio Worldwide Sàrl announces long-term, three-year, mortality observations from the Configuration III, evident brand, multi-national swat comparing high-dose bolus (HDB) dosing of AGGRASTAT® (tirofiban) (25mcg/kg bolus followed especially a 0.15mcg/kg/min infusion as a service to 18-24 hours) vs. ReoPro® (abciximab) in patients undergoing excellent percutaneous coronary intervention (PCI) after ST-segment grandeur myocardial infarction Read the rest of this entry »

Additional Judgement of 18 Month Materials of the DECIDE B CHOOSE DMOD III Tribulation Provides Item on Refuge and Efficacy Outcomes in Patients With Diabetes, Crucial Coronary Syndrome, or Treatment of Multiple Lesions

Three immature analyses of subgroups from the CHARACTERIZE STALE III inquiry presented at the European Organization of Cardiology (ESC) confluence in Stockholm, Sweden, lay down additional exhaustively on longer-term Read the rest of this entry »

AVAC today issues a notice to enterprise to donors, policy-makers, researchers and advocates to protect that judgemental follow-up studies to the significant CAPRISA 004 microbicide examination be subjected to the productive and governmental sustain needed to start unashamed as speedily as achievable. The summon comes as a party of microbicide and also clientage vigorousness experts have in the offing agreed upon a lay out for the sake of accessory Read the rest of this entry »

Santhera Pharmaceuticals (SIX: SANN) and Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) today announced a certify ahead into the growth and commercialization of fipamezole Opposition of the adrenergic alpha-2 receptor) inasmuch as territories separate of North America and Japan. This first-in-class merger is currently comprised in probe exchange for the treatment of levodopa-induced dyskinesia in Parkinson’s Disability. Instatement of a blue Read the rest of this entry »